Intract Pharma and N&S Pharmacy Investment announce partnership to develop orally-delivered GLP-1R agonist peptide therapeutic
Intract Pharma and Elasmogen Ltd announce collaboration to discover and develop novel, orally-delivered protein therapeutics
January 29, 2020 | Events
Intract Pharma to Present at the 22nd BIO CEO & Investor Conference
October 24, 2019 | Featured
Intract’s Soteria® and Phloral® Technologies Highlighted Among Revolutionary Approaches to Crack Oral Biologics Delivery Challenge
Carus Animal Health and Intract Pharma Enter Agreement to Develop Novel Drug Delivery Technology
April 05, 2019 | Featured
Intract Pharma Limited and Neopharma Japan Enter into a Collaboration to Develop a Novel Treatment for Gastrointestinal Diseases using Intract’s Proprietary Drug Delivery Technologies
Intract Pharma announces market launch of a first Phloral® colon-targeting product
February 15, 2019 | Events
10th Global Drug Delivery and Formulation Summit, 11-13 March 2019
Antibody Engineering and Therapeutics Conference, December 9-13, 2018
